Literature DB >> 15991287

Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphy.

Etsushi Kawamura1, Daiki Habu, Takehiro Hayashi, Ai Oe, Jin Kotani, Hirotaka Ishizu, Kenji Torii, Joji Kawabe, Wakaba Fukushima, Takashi Tanaka, Shuhei Nishiguchi, Susumu Shiomi.   

Abstract

AIM: To examine the correlation between the porto-systemic hypertension evaluated by portal shunt index (PSI) and life-threatening complications, including hepatocellular carcinoma (HCC), liver failure (Child-Pugh stage progression), and esophagogastric varices.
METHODS: Two hundred and twelve consecutive subjects with HCV-related cirrhosis (LC-C) underwent per-rectal portal scintigraphy. They were allocated into three groups according to their PSI: group I, PSI< or =10%; group II, 10%<PSI<30%; and group III, 30%< or =PSI. Of these, selected 122 Child-Pugh stage A (Child A) subjects were included in analysis (a mean follow-up period of 5.9+/-5.4 years, range 6 mo-21 years).
RESULTS: No significant correlation between PSI and cumulative probability of HCC incidence was observed. Cumulative probability of Child A to B progression was tended to be higher in group III than in group I, and significantly higher in group III than in group II (62% vs 34%, 62% vs 37%; P = 0.060, <0.01; respectively). Cumulative probability of varices tended to be higher in group III than in group I (31% vs 12%, P = 0.090). On multivariate analyses, significant correlation between PSI and Child A to B progression was observed, and no significant correlation between PSI and HCC incidence or varices progression was observed.
CONCLUSION: Patients with LC-C of Child A will progress to Child B rapidly after their PSI reaches 30% or higher. PSI can be used to predict occult progressive porto-systemic shunting and liver failure non-invasively. It indicates that PSI may play an important role in follow-up of the porto-systemic hypertension gradient for outpatients with LC unlike hepatic venous catheterization.

Entities:  

Mesh:

Year:  2005        PMID: 15991287      PMCID: PMC4504890          DOI: 10.3748/wjg.v11.i25.3882

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.

Authors:  Giovanna Fattovich; Irene Zagni; Eliseo Minola; Martina Felder; Pierangelo Rovere; Antonio Carlotto; Sergio Suppressa; Anna Miracolo; Claudio Paternoster; Caterina Rizzo; Angelo Rossini; Paolo Benedetti; Marco Capanni; Chiara Ferrara; Paolo Costa; Tosca Bertin; Maurizio Pantalena; Lorenzo Lomonaco; Chiara Scattolini; Giuseppe Mazzella; Massimo Giusti; Sergio Boccia; Stefano Milani; Renato Marin; Maria Lisa Ribero; Alessandro Tagger
Journal:  J Hepatol       Date:  2003-11       Impact factor: 25.083

Review 2.  Liver transplantation: problems and perspectives.

Authors:  J Fevery
Journal:  Hepatogastroenterology       Date:  1998 Jul-Aug

3.  Per-rectal portal scintigraphy: comparison between technetium-99m, thallium-201, and iodine-123-HIPDM.

Authors:  D Urbain; O Jeghers; H R Ham
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

4.  Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study.

Authors:  J Vorobioff; R J Groszmann; E Picabea; M Gamen; R Villavicencio; J Bordato; I Morel; M Audano; H Tanno; E Lerner; M Passamonti
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

5.  Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.

Authors:  H R Rosen; D Gretch; E Kaufman; S Quan
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

6.  Natural history of hepatitis C in HIV-negative patients with congenital coagulation disorders.

Authors:  K Meijer; E B Haagsma; T Kok; J Schirm; W M Smid; J van der Meer
Journal:  J Hepatol       Date:  1999-09       Impact factor: 25.083

7.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

Review 8.  Small-for-size graft in living donor liver transplantation: how far should we go?

Authors:  Tetsuya Kiuchi; Koichi Tanaka; Takashi Ito; Fumitaka Oike; Yasuhiro Ogura; Yasuhiro Fujimoto; Kohei Ogawa
Journal:  Liver Transpl       Date:  2003-09       Impact factor: 5.799

9.  An assessment of the management of acute bleeding varices: a multicenter prospective member-based study.

Authors:  Darius Sorbi; Christopher J Gostout; David Peura; David Johnson; Frank Lanza; P Gregory Foutch; Cathy D Schleck; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

10.  Effect of propranolol on portosystemic collateral circulation estimated by per-rectal portal scintigraphy with technetium-99m pertechnetate.

Authors:  H Bołdys; M Hartleb; K Rudzki; A Nowak; S Nowak
Journal:  J Hepatol       Date:  1995-02       Impact factor: 25.083

View more
  1 in total

1.  Staging of portal hypertension and portosystemic shunts using dynamic nuclear medicine investigations.

Authors:  Mircea Dragoteanu; Ioan-A Balea; Liliana-A Dina; Cecilia-D Piglesan; Ioana Grigorescu; Stefan Tamas; Sabin-O Cotul
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.